PARK2 gene variants in Korean patients with Parkinson’s disease

被引:0
作者
Min-young Park
In won Park
Chun hwa Ihm
Eunhee Kim
机构
[1] Chungnam National University,Department of Biological Sciences
[2] Chungnam National University,Graduate School of New Drug Discovery and Development
[3] Eulji University Hospital,Department of Laboratory Medicine
来源
Genes & Genomics | 2016年 / 38卷
关键词
Parkinson’s disease; Variant; Korean PD patients;
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in PARK2 are considered a common cause of Parkinson’s disease (PD). To assess the frequency of PARK2 mutations in the Korean population, we screened the PARK2 gene in 83 Korean PD patients: two young onset (YO, ≤ 49), 32 middle onset (MO, 50–69) and 49 late onset (LO, ≥ 70). Detection of the point mutations was performed by direct sequencing of the PARK2 exons, and exonic rearrangements were analyzed using multiplex ligation-dependent probe amplification. Five known PARK2 variants were identified in 53 (63.9 %) of the Korean PD patients: two missense mutations (Y267H and M458L) and three polymorphisms (S167N, L272I and V380L). We also found an increased frequency of PARK2 variants in PD patients and a lowered PD age at onset (AAO) in those having two variants, suggesting that the genetic variation in PARK2 gene might be a genetic risk factor of PD in Korean population.
引用
收藏
页码:163 / 169
页数:6
相关论文
共 272 条
[1]  
Ambroziak W(2015)Genomic instability in the PARK2 locus is associated with Parkinson’s disease J Appl Genet 10 e1003935-269
[2]  
Koziorowski D(2014)Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin PLoS Comput Biol 6 e19720-248
[3]  
Duszyc K(2011)Parkin mediates apparent E2-independent monoubiquitination in vitro and contains an intrinsic activity that catalyzes polyubiquitination PLoS ONE 9 263-1218
[4]  
Gorka-Skoczylas P(2008)Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease Neurogenetics 10 244-S39
[5]  
Potulska-Chromik A(2014)Analysis of dosage mutation in PARK2 among Korean patients with early-onset or familial Parkinson’s disease J Clin Neurol 91 1161-71
[6]  
Slawek J(2011)What genetics tells us about the causes and mechanisms of Parkinson’s disease Physiol Rev 25 S32-801
[7]  
Hoffman-Zacharska D(2010)The role of parkin in familial and sporadic Parkinson’s disease Mov Disord 13 69-224
[8]  
Caulfield TR(2014)Parkin plays a role in sporadic Parkinson’s disease Neurodegener Dis 60 796-701
[9]  
Fiesel FC(2003)Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease Neurology 73 199-2075
[10]  
Moussaud-Lamodiere EL(2013)Integrated pathways of parkin control over mitochondrial maintenance—relevance to Parkinson’s disease pathogenesis Acta Neurobiol Exp (Wars) 28 698-1656